20 results
8-K
EX-99.1
RPTX
Repare Therapeutics Inc
25 Jan 24
Repare Therapeutics Announces Achievement of $40 Million Roche Clinical Milestone Payment
2:29pm
development for camonsertib + PARP inhibitor combinations.
“This milestone is a key achievement for us, demonstrating Roche’s commitment to the global clinical
DEF 14A
c35rh6tff0p6fijpnaup
1 Apr 21
Definitive proxy
7:36am
10-K
7qb2wm8umqz
4 Mar 21
Annual report
5:25pm
424B4
mt6839mq
19 Jun 20
Prospectus supplement with pricing info
4:38pm
S-1/A
EX-10.3
b90298du3 9v
15 Jun 20
IPO registration (amended)
6:18am
S-1/A
0pjqafi 4cygzh
15 Jun 20
IPO registration (amended)
6:18am
S-1/A
EX-10.5
wlex1qvua4 55
15 Jun 20
IPO registration (amended)
6:18am
S-1
9oyle
29 May 20
IPO registration
5:26pm
S-1
EX-3.1
5jkv 5se4
29 May 20
IPO registration
5:26pm
S-1
EX-4.3
76703x7k1zz64pd
29 May 20
IPO registration
5:26pm
DRS/A
qqc9840 l30
12 May 20
Draft registration statement (amended)
12:00am
DRS
cwmfgru
6 Apr 20
Draft registration statement
12:00am
DRS
EX-3.1
kzj7l3
6 Apr 20
Draft registration statement
12:00am
- Prev
- 1
- Next